Get the Stockscreener App
49.86
4.13%
-2.15
Carlyle Group Inc stock is traded at $49.86, with a volume of 2.53M.
It is down -4.13% in the last 24 hours and down -11.61% over the past month.
The Carlyle Group is one of the world's largest alternative-asset managers, with $447.4 billion in total AUM, including $313.6 billion in fee-earning AUM, at the end of September 2024. The company has three core business segments: private equity, which includes private equity, real estate, infrastructure, and natural resources funds (accounting for 33% of fee-earning AUM and 57% of base management fees during 2023), global credit (51% and 27%) and investment solutions (16% and 16%). The firm primarily serves institutional investors and high-net-worth individuals. Carlyle operates through 29 offices across five continents, serving more than 2,900 active carry fund investors from 88 countries.
See More
Previous Close:
$52.01
Open:
$51.94
24h Volume:
2.53M
Relative Volume:
1.18
Market Cap:
$17.83B
Revenue:
$2.26B
Net Income/Loss:
$117.50M
P/E Ratio:
166.20
EPS:
0.3
Net Cash Flow:
$-220.60M
1W Performance:
-3.69%
1M Performance:
-11.61%
6M Performance:
+24.15%
1Y Performance:
+11.79%
1-Day Range:
$49.44
$52.14
1-Week Range:
$49.44
$53.47
52-Week Range:
$36.65
$57.50
Carlyle Group Inc Stock (CG) Company Profile
Name
Carlyle Group Inc
Sector
Industry
Phone
202 729 5626
Address
C/O THE CARLYLE GROUP, WASHINGTON, DC
Compare CG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CG
Carlyle Group Inc
|
49.86 | 17.83B | 2.26B | 117.50M | -220.60M | 0.30 |
|
BLK
Blackrock Inc
|
974.22 | 150.89B | 20.41B | 6.37B | 4.05B | 42.00 |
|
BX
Blackstone Inc
|
158.38 | 121.75B | 10.93B | 2.78B | 4.14B | 3.63 |
|
KKR
Kkr Co Inc
|
132.22 | 117.44B | 21.64B | 3.08B | 7.75B | 3.28 |
|
BAM
Brookfield Asset Management Ltd
|
58.57 | 94.53B | 0 | 1.04B | 0 | 1.27 |
|
BN
Brookfield Corporation
|
58.86 | 88.79B | 86.01B | 641.00M | -4.81B | 0.3007 |
Carlyle Group Inc Stock (CG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-03-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Sep-12-24 | Initiated | Wells Fargo | Equal Weight |
| Aug-27-24 | Initiated | Redburn Atlantic | Buy |
| Aug-06-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Jan-19-24 | Downgrade | Citigroup | Buy → Neutral |
| Jan-04-24 | Initiated | TD Cowen | Market Perform |
| Nov-29-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-05-23 | Initiated | Wolfe Research | Peer Perform |
| May-19-23 | Initiated | Citigroup | Buy |
| Mar-02-23 | Initiated | Barclays | Overweight |
| Jan-03-23 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
| Oct-19-22 | Initiated | Credit Suisse | Outperform |
| Sep-06-22 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-09-22 | Downgrade | Jefferies | Buy → Hold |
| Jul-29-22 | Upgrade | Evercore ISI | In-line → Outperform |
| Jun-08-22 | Initiated | JMP Securities | Mkt Outperform |
| Dec-16-21 | Initiated | BofA Securities | Buy |
| Sep-13-21 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Aug-11-21 | Upgrade | Deutsche Bank | Hold → Buy |
| Feb-19-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jan-19-21 | Upgrade | Keefe Bruyette | Mkt Perform → Outperform |
| Nov-20-20 | Upgrade | BofA Securities | Underperform → Buy |
| Oct-12-20 | Upgrade | Citigroup | Neutral → Buy |
| Jun-08-20 | Downgrade | Citigroup | Buy → Neutral |
| Apr-15-20 | Upgrade | Citigroup | Neutral → Buy |
| Mar-23-20 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Feb-06-20 | Downgrade | Citigroup | Buy → Neutral |
| Feb-06-20 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
| Dec-12-19 | Downgrade | UBS | Buy → Neutral |
| Oct-08-19 | Initiated | BMO Capital Markets | Market Perform |
| Sep-23-19 | Reiterated | BofA/Merrill | Neutral |
| Aug-05-19 | Initiated | Barclays | Equal Weight |
| May-21-19 | Downgrade | Credit Suisse | Outperform → Neutral |
| Mar-29-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jan-04-19 | Upgrade | Goldman | Neutral → Buy |
| Nov-14-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Mar-12-18 | Upgrade | Citigroup | Neutral → Buy |
| Feb-14-18 | Upgrade | Jefferies | Hold → Buy |
| Oct-10-17 | Downgrade | Citigroup | Buy → Neutral |
| Jun-08-17 | Upgrade | BofA/Merrill | Neutral → Buy |
| May-11-17 | Upgrade | Credit Suisse | Neutral → Outperform |
View All
Carlyle Group Inc Stock (CG) Latest News
Bluebird Bio to Be Acquired by Carlyle Group, SK Capital - The Wall Street Journal
Bluebird bio Agrees to be Acquired by Carlyle Group, SK Capital Partners; Shares Fall Sharply - Marketscreener.com
Gene therapy maker bluebird to go private in discounted deal amid cash crunch - Reuters
Carlyle Group Explores Asset-Based Finance as Key Growth SectorNews and Statistics - IndexBox, Inc.
Sector Update: Financial Stocks Advance Pre-Bell Friday -February 21, 2025 at 09:27 am EST - Marketscreener.com
Bluebird Bio Announces Definitive Agreement To Be Acquired By Carlyle And SK Capital - Marketscreener.com
Carlyle price target lowered to $47 from $50 at BofA - Yahoo Finance
What's Going On With Gene Therapy Company Bluebird Bio Stock Today? - Benzinga
What's Driving the Market Sentiment Around Carlyle Group? - Benzinga
bluebird bio announces take-private deal with Carlyle and SK Capital - MSN
Bluebird Bio To Be Taken Private By Carlyle And SK Capital Partners - Nasdaq
Carlyle and SK Capital to acquire bluebird bio By Investing.com - Investing.com UK
Bluebird bio to be taken private by Carlyle and SK Capital amid cash crunch -February 21, 2025 at 08:14 am EST - Marketscreener.com
Bluebird bio Agrees to be Acquired by Carlyle Group, SK Capital Partners; Trading Halted Pre-Bell - Marketscreener.com
Bluebird bio agrees to be acquired by Carlyle and SK Capital -February 21, 2025 at 07:36 am EST - Marketscreener.com
bluebird bio Announces Definitive Agreement to be Acquired by Carlyle and SK Capital - Business Wire
Carlyle Group Among Final Bidders for HgCapital's smartTrade Technologies -February 21, 2025 at 06:05 am EST - Marketscreener.com
Carlyle and SK Capital to take gene therapy firm bluebird bio private - PE Hub
Carlyle COO Touts Asset-Based Finance as Next Frontier - Bloomberg
Carlyle group general counsel Jeffrey Ferguson sells $13.3 million in shares - Investing.com
Carlyle Group General Counsel Sells 250,000 Shares - TradingView
Carlyle and Thoma Bravo Among Final Bidders for SmartTrade TechnologiesNews and Statistics - IndexBox, Inc.
Carlyle, Thoma Bravo Shortlisted in Bidding for SmartTrade - Yahoo Finance
The Search For 7% Investment Grade Yields, Part 2: Carlyle And Its Baby Bond - Seeking Alpha
Carlyle's India Head on Hexaware Technologies IPO -February 20, 2025 at 05:48 am EST - Marketscreener.com
Carlyle remains committed to Hexaware, as it gets listed - Communications Today
Ex-Dividend Reminder: Primerica, Carlyle Group and Abrdn Healthcare Opportunities Fund - Nasdaq
Goldman Sachs Partner Alibair Exits to Join Carlyle in New Role - Bloomberg
Carlyle-backed IT exporter Hexaware valued at $5 bn on market debut day - Business Standard
Carlyle Group’s Hexaware to Debut After India’s First Billion-Dollar IPO of Year - Bloomberg
Carlyle Group's Hexaware to Debut After India's First Billion-Dollar IPO of Year - Financial Post
Carlyle Group's SWOT analysis: stock outlook amid mixed Q4 results - MSN
Carlyle Group's SWOT analysis: stock outlook amid mixed Q4 results By Investing.com - Investing.com Nigeria
The Carlyle Group Inc. (NASDAQ:CG) Stake Lessened by Empowered Funds LLC - MarketBeat
The Carlyle Group (NASDAQ:CG) Posts Earnings Results, Misses Expectations By $0.08 EPS - MarketBeat
The Carlyle Group Inc. (NASDAQ:CG) Is About To Go Ex-Dividend, And It Pays A 2.7% Yield - Yahoo Finance UK
Sumitomo Mitsui Trust Group Inc. Acquires 7,891 Shares of The Carlyle Group Inc. (NASDAQ:CG) - MarketBeat
The Carlyle Group (NASDAQ:CG) Upgraded by StockNews.com to "Hold" Rating - MarketBeat
The Carlyle Group (NASDAQ:CG) Given New $55.00 Price Target at Barclays - MarketBeat
The Carlyle Group Inc. (NASDAQ:CG) Declares $0.35 Quarterly Dividend - MarketBeat
Stanley Laman Group Ltd. Cuts Stock Holdings in The Carlyle Group Inc. (NASDAQ:CG) - MarketBeat
Polaris Capital Management LLC Has $37.62 Million Stake in The Carlyle Group Inc. (NASDAQ:CG) - MarketBeat
Sumitomo Mitsui DS Asset Management Company Ltd Buys 7,539 Shares of The Carlyle Group Inc. (NASDAQ:CG) - MarketBeat
Carlyle acquires majority stake in Highway-Roop platform - Yahoo
Wells Fargo & Company Issues Pessimistic Forecast for The Carlyle Group (NASDAQ:CG) Stock Price - MarketBeat
Evercore ISI holds Carlyle Group stock with $51 target - MSN
Citi maintains Neutral on Carlyle Group with $55 target - MSN
The Carlyle Group (NASDAQ:CG) Trading Down 4.9% on Disappointing Earnings - MarketBeat
Mirae Asset Global Investments Co. Ltd. Has $1.43 Million Position in The Carlyle Group Inc. (NASDAQ:CG) - MarketBeat
The Carlyle Group Inc. (NASDAQ:CG) Shares Sold by abrdn plc - MarketBeat
The Carlyle Group Target of Unusually Large Options Trading (NASDAQ:CG) - MarketBeat
Carlyle Group Inc Stock (CG) Financials Data
Revenue
Net Income
Cash Flow
EPS
Carlyle Group Inc Stock (CG) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Ferguson Jeffrey W. | General Counsel |
Feb 18 '25 |
Sale |
53.20 |
102,342 |
5,444,594 |
1,242,781 |
0.94%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):